Targeting glioblastoma tumor hyaluronan to enhance therapeutic interventions that regulate metabolic cell properties

The control of aberrant hyaluronan metabolism in the tumor microenvironment can improve the efficacy of current treatments. Bioengineered preclinical models demonstrate potential to predict, stratify and accelerate the development of cancer treatments.